Volume 11, Number 9—September 2005
Research
Trypanosomiasis Control, Democratic Republic of Congo, 1993–2003
Table 1
Type of donor | 1993–1997 |
1998–2003 |
|||
---|---|---|---|---|---|
US$ | Percentage | US$ | Percentage | ||
Belgian government | Bilateral | 4,508,774 | 69.2 | 14,566,002 | 87.1 |
European union | Bilateral | 1,337,946 | 20.5 | 656,367 | 3.9 |
Congolese government | NA | 270,611 | 4.2 | 329,441 | 2.0 |
WHO | Multilateral | 0 | 0.0 | 527,698 | 3.2 |
Pain pour le Monde‡ | NGO | 70,430 | 1.1 | 68,411 | 0.4 |
MSF‡ | NGO | 0 | 0.0 | 104,233 | 0.6 |
MEMISA‡ | NGO | 70,965 | 1.1 | 462,906 | 2.8 |
AFRICA‡ | NGO | 0 | 0.0 | 6,440 | 0.1 |
Caritas–Germany‡ | NGO | 254,506 | 3.9 | 0 | 0.0 |
Total | 6,513,232 | 100.0 | 16,721,496 | 100.0 | |
Total per year | 1,302,646 | 2,786,916 |
*NA., not applicable; NGO, nongovernmental organization; WHO, World Health Organization; MSF, Médecins Sans Frontières Belgique; MEMISA, Medische Missie Samenwerking; AFRICA, Association des Femmes pour les Rencontres Intellectuelles et Culturelles en Afrique.
†Sanofi-Aventis/Bayer in-kind drug donation not included; see text.
‡The amounts mentioned for NGOs are limited to the "own funds," i.e., funds that they had privately raised and spent on sleeping sickness control. Several NGOs were implementing HAT control activities with funds provided by the bilateral or multilateral donors.
Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.